ERBB2 and breast carcinoma: Yet another study found that erastin-treated HER2-positive breast cancer cells presented significantly high expression levels of circ-COL1A2, circ-SC5D, circ-MSH2, circ-ACRBP, and circ-DTL compared with untreated cells (Wang et al., 2022a).